Total Neoadjuvant Therapy Should Be Used Routinely and Considered the New Standard for Locally Advanced (T3/4 or N+) Rectal Cancer (Pro)

Debater(s)

• 

  Y. Nancy You, MD

  Professor, Department of Colon and Rectal Surgery
  University of Texas MD Anderson Cancer Center

  Disclosure: Disclosure information not submitted.